Malignant Pancreatic Insulinoma

specific

An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin. It displays vascular invasion and metastasizes to other anatomic sites.

19

Centers

0

Active Trials

Cancer Funding

Top Centers for Malignant Pancreatic Insulinoma(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
52.6
2
NCI Comprehensive
52.6
3
NCI Comprehensive
52.6
452.6
5
NCI Comprehensive
52.6
652.6
7
NCI Comprehensive
52.6
8
NCI Comprehensive
52.6
9
NCI Comprehensive
52.6
10
NCI Comprehensive
52.6
11
NCI Comprehensive
52.6
1252.6
13
NCI Comprehensive
52.6
1452.6
15
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
52.6
1652.6
1752.6
1852.6
1952.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →